CA2076050A1 - Esters d'alkyliques ramifies d'acides 4-bis(chloroethyl)aminophenylalkylcarboxyliques pour le traitement des tumeurs primaires et metastasiques du systeme lymphatique, ainsi que des cancers du sein et des ovaires - Google Patents
Esters d'alkyliques ramifies d'acides 4-bis(chloroethyl)aminophenylalkylcarboxyliques pour le traitement des tumeurs primaires et metastasiques du systeme lymphatique, ainsi que des cancers du sein et des ovairesInfo
- Publication number
- CA2076050A1 CA2076050A1 CA 2076050 CA2076050A CA2076050A1 CA 2076050 A1 CA2076050 A1 CA 2076050A1 CA 2076050 CA2076050 CA 2076050 CA 2076050 A CA2076050 A CA 2076050A CA 2076050 A1 CA2076050 A1 CA 2076050A1
- Authority
- CA
- Canada
- Prior art keywords
- chlorambucil
- treatment
- tertiary butyl
- butyl ester
- ovaries
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47807590A | 1990-02-09 | 1990-02-09 | |
| US478,075 | 1990-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2076050A1 true CA2076050A1 (fr) | 1991-08-10 |
Family
ID=23898417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2076050 Abandoned CA2076050A1 (fr) | 1990-02-09 | 1991-02-08 | Esters d'alkyliques ramifies d'acides 4-bis(chloroethyl)aminophenylalkylcarboxyliques pour le traitement des tumeurs primaires et metastasiques du systeme lymphatique, ainsi que des cancers du sein et des ovaires |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0514437A4 (fr) |
| AU (1) | AU639758B2 (fr) |
| CA (1) | CA2076050A1 (fr) |
| WO (1) | WO1991011998A1 (fr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US478075A (en) * | 1892-07-05 | Coffee-pot | ||
| US4835182A (en) * | 1987-08-21 | 1989-05-30 | The United States Of America As Represented By The Department Of Health And Human Services | Enhancing drug delivery to the brain |
-
1991
- 1991-02-08 AU AU72387/91A patent/AU639758B2/en not_active Ceased
- 1991-02-08 CA CA 2076050 patent/CA2076050A1/fr not_active Abandoned
- 1991-02-08 EP EP19910903814 patent/EP0514437A4/en not_active Withdrawn
- 1991-02-08 WO PCT/US1991/000763 patent/WO1991011998A1/fr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU7238791A (en) | 1991-09-03 |
| WO1991011998A1 (fr) | 1991-08-22 |
| AU639758B2 (en) | 1993-08-05 |
| EP0514437A1 (fr) | 1992-11-25 |
| EP0514437A4 (en) | 1993-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5707131B2 (ja) | 抗炎症性化合物とその用途 | |
| CA2689717C (fr) | Medicament anti-cancereux non toxique combinant de l'ascorbate, du magnesium et une naphtoquinone | |
| AU2002311985B9 (en) | Methods for inhibiting angiogenesis | |
| An et al. | Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor | |
| US10729669B2 (en) | Compositions and methods for treating cancer | |
| AU619022B2 (en) | Pharmaceutical compositions for the inhibition of tumor metastasis | |
| US20150183754A1 (en) | Fatty acid inhibitors | |
| JP4162994B2 (ja) | 諸疾患状態の処置のための薬物に使用する化合物とその製造方法 | |
| KR100701539B1 (ko) | 멜라가트란의 신규 용도 | |
| US5750515A (en) | Cancer metastasis inhibitor | |
| Patterson et al. | Combretastatin A-4 phosphate | |
| US20200352890A1 (en) | Reversibly protected thiolated electrophilic fatty acids as prodrugs | |
| CA2076050A1 (fr) | Esters d'alkyliques ramifies d'acides 4-bis(chloroethyl)aminophenylalkylcarboxyliques pour le traitement des tumeurs primaires et metastasiques du systeme lymphatique, ainsi que des cancers du sein et des ovaires | |
| US20180153870A1 (en) | Biperiden for treating cancer | |
| DE50211672D1 (de) | Urokinase-inhibitoren | |
| CA3039030A1 (fr) | Nouveaux derives nitroxydes reversibles de nitroalcenes qui induisent des reactions de nitrosation et d'alkylation | |
| ES2217265T3 (es) | Inhibidor de la metastasis de tumores malignos. | |
| KR100457113B1 (ko) | 세라마이드류 또는 그 유도체와 다이메틸스핑고신을 유효성분으로 포함하는 방사선민감도 증진제 | |
| BR112020019221A2 (pt) | Composições para prevenir ou tratar olho seco | |
| EP1299400B1 (fr) | Nouveaux composes cytotoxiques et leur utilisation | |
| US11352382B2 (en) | Mito-lonidamine, compositions and methods of use | |
| TW201021801A (en) | A pharmaceutical composition for the treatment of cancers | |
| WO2023159048A2 (fr) | Inhibiteur de stat3 à petites molécules pour traitement du cancer du sein triple négatif | |
| JPH05505394A (ja) | リンパ系の初期および転移した腫瘍並びに乳および子宮ガン治療用４―ビス（クロロエチル）アミノフェニル―アルキルカルボン酸の分鎖アルキルエステル | |
| JP2023554532A (ja) | 医薬組成物の肺癌治療における使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |